Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.

ABSTRACT:

Objective

To estimate the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in health care personnel.

Methods

The Mayo Clinic Serology Screening Program was created to provide a voluntary, two-stage testing program for SARS-CoV-2 antibodies to health care personnel. The first stage used a dried blood spot screening test initiated on June 15, 2020. Those participants identified as reactive were advised to have confirmatory testing via a venipuncture. Venipuncture results through August 8, 2020, were considered. Consent and authorization for testing was required to participate in the screening program. This report, which was conducted under an institutional review board-approved protocol, only includes employees who have further authoriz

SUBMITTER: Carter RE 

PROVIDER: S-EPMC7997730 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature